FDA approval summary: pembrolizumab for treatment of metastatic non‐small cell lung cancer: first‐line therapy and beyond
L Pai‐Scherf, GM Blumenthal, H Li… - The …, 2017 - academic.oup.com
Abstract On October 24, 2016, the US Food and Drug Administration (FDA) approved
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.
L Pai‐Scherf, GM Blumenthal, H Li… - …, 2017 - search.ebscohost.com
Abstract On October 24, 2016, the US Food and Drug Administration (FDA) approved
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond
L Pai-Scherf, GM Blumenthal, H Li, S Subramaniam… - 2017 - pubmed.ncbi.nlm.nih.gov
On October 24, 2016, the US Food and Drug Administration (FDA) approved pembrolizumab
(Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of patients with …
(Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of patients with …
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond
L Pai-Scherf, GM Blumenthal, H Li, S Subramaniam… - The Oncologist, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> On October 24, 2016, the US Food and Drug
Administration (FDA) approved pembrolizumab (Keytruda; Merck & Co., Inc., https://www …
Administration (FDA) approved pembrolizumab (Keytruda; Merck & Co., Inc., https://www …
[PDF][PDF] FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non‐Small Cell Lung Cancer: First‐Line Therapy and Beyond
L Pai‐Scherf, GM Blumenthal, H Li… - The …, 2017 - Wiley Online Library
Abstract On October 24, 2016, the US Food and Drug Administration (FDA) approved
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.
L Pai-Scherf, GM Blumenthal, H Li, S Subramaniam… - The …, 2017 - europepmc.org
Abstract On October 24, 2016, the US Food and Drug Administration (FDA) approved
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
[HTML][HTML] FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non‐Small Cell Lung Cancer: First‐Line Therapy and Beyond
L Pai‐Scherf, GM Blumenthal, H Li… - The …, 2017 - ncbi.nlm.nih.gov
Abstract On October 24, 2016, the US Food and Drug Administration (FDA) approved
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …
pembrolizumab (Keytruda; Merck & Co., Inc., https://www. merck. com) for treatment of …